Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, February 11, 2015
A new white paper released today by Exel, the North American leader in contract logistics, in conjunction with its sister company DHL Supply Chain, the world’s leading logistics company, has revealed that theft, pharmaceutical counterfeiting, ...
read more
Exela Pharma Sciences is voluntarily recalling 49 lots of Sodium Bicarbonate Injection, USP, 8.4%, 50 mEq/50 mL vial, 20- count carton, to the consumer level.
read more
Friday, November 04, 2022
Exelixis, Inc. and Catalent, Inc. announced a new license agreement under which Catalent’s Redwood Bioscience subsidiary will grant Exelixis an exclusive license to three target programs with lead antibody and/or ADC candidates.
read more
Thursday, August 01, 2019
Exelixis has entered into an exclusive collaboration, option and license agreement with Aurigene Discovery Technologies Limited.
read more
Thursday, September 10, 2020
Exelixis and Catalent announced a partnership under which Catalent’s Redwood Bioscience subsidiary will develop multiple ADCs for Exelixis using Catalent’s proprietary SMARTag site-specific bioconjugation technology.
read more
Wednesday, September 09, 2020
Catalent’s Redwood Bioscience subsidiary will develop multiple antibody-drug conjugates for Exelixis using Catalent’s proprietary SMARTag site-specific bioconjugation technology.
read more
Exelixis has entered into a collaboration and license agreement with StemSynergy for the discovery and development of novel oncology compounds targeting Casein Kinase 1 alpha.
read more
Eximia Research announced the integration of Tidewater Clinical Research into its national network of clinical trial sites. This strategic development unites Tidewater's longstanding expertise in Women's Health and Ophthalmology with Eximia's ...
read more
Tuesday, December 02, 2025
eXmoor Pharma and the Translational Research Office (TRO) at University College London (UCL) have formed a strategic collaboration to accelerate the development of novel cell and gene therapies (CGTs) from academic research into clinical application.
read more
Exonbio has launched the SARS-CoV-2 Nucleocapsid recombinant monoclonal antibodies for the global IVD and research communities in support of efforts to combat the pandemic.
read more
Exonbio has launched the SARS-CoV-2 Spike recombinant monoclonal antibodies for the global IVD and research communities in support of efforts to combat the pandemic.
read more
Exopharm Limited has signed a Master Collaborative Services Agreement (MSA) with the Astellas Institute for Regenerative Medicine (AIRM).
read more
Tuesday, January 21, 2020
Exosomics has implemented NanoFCM’s NanoAnalyzer instrument to offer sophisticated contract research and measurement services worldwide.
read more
Friday, November 06, 2015
Exostar, a provider of secure cloud-based solutions that improve identity access management, is now certified by SAFE-BioPharma Association to issue SHA-2 compliant public key infrastructure (PKI) digital certificates for use in the life sciences and...
read more
Exothera has acquired the NevoLine Upstream manufacturing platform, the latest equipment of Univercells Technologies.
read more